Thomas E. Polen's FY2025 total of $17.13M ranks at the 78.6th percentile among 174 sector CEOs · sector median $7.11M · p75 $15.12M.
| Executive | Title | Salary | Bonus | Stock | Option | Incentive | Other | Total | Source |
|---|---|---|---|---|---|---|---|---|---|
| Thomas E. Polen | CEO | $1.40M | — | — | — | $1.85M | — | $17.13M | SEC ↗ |
| Christopher J. DelOrefice | CFO | $0.84M | — | — | — | $0.72M | — | $5.88M | SEC ↗ |
| Michael C. Feld | ChiefRevenue Officer and President,Life Sciences Segment | $0.78M | — | — | — | $0.53M | — | $4.10M | SEC ↗ |
| Michael D. Garrison | Presidentand President, MedicalEssentials and BioPharmaSystems Segments | $0.77M | — | — | — | $0.53M | — | $3.65M | SEC ↗ |
| Richard E. Byrd | President andPresident, InterventionalSegment | $0.76M | — | — | — | $0.59M | — | $3.40M | SEC ↗ |
Every figure links to its source SEC proxy (DEF 14A). Extraction: edgartools/ECD-XBRL.